The present invention is on the field of prevention and/or treatment of adipogenesis and obesity. According to the invention mineralcorticoid receptor antagonists are used as the therapeutically active principle. The mineralcorticoid receptor antagonists used in this invention are capable of displacing the endogenous glucocorticoid cortisol from the mineralcorticoid receptor.

MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CORTICOID-INDUCED OBESITY

CAPRIO M;ROSANO G;
2012-01-01

Abstract

The present invention is on the field of prevention and/or treatment of adipogenesis and obesity. According to the invention mineralcorticoid receptor antagonists are used as the therapeutically active principle. The mineralcorticoid receptor antagonists used in this invention are capable of displacing the endogenous glucocorticoid cortisol from the mineralcorticoid receptor.
2012
File in questo prodotto:
File Dimensione Formato  
MINERALCORTICOID RECEPTOR ANTAGONISTS_brevetto.pdf

non disponibili

Dimensione 1.89 MB
Formato Adobe PDF
1.89 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12078/113
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact